iNtRON Biotechnology, Inc. Share Price
Equities
A048530
KR7048530000
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,970 KRW | -1.13% | +1.31% | -20.62% |
Sales 2022 | 14.01B 10.11M 844M | Sales 2023 | 9.59B 6.92M 578M | Capitalization | 291B 210M 17.56B |
---|---|---|---|---|---|
Net income 2022 | 5.71B 4.12M 344M | Net income 2023 | -9.7B -7M -584M | EV / Sales 2022 | 13.8 x |
Net cash position 2022 | 76.58B 55.29M 4.61B | Net cash position 2023 | 56.78B 41M 3.42B | EV / Sales 2023 | 24.5 x |
P/E ratio 2022 |
-23,726
x | P/E ratio 2023 |
-30.1
x | Employees | 81 |
Yield 2022 * |
-
| Yield 2023 |
1.14% | Free-Float | 81.28% |
1 day | -1.13% | ||
1 week | +1.31% | ||
Current month | -4.13% | ||
1 month | -4.13% | ||
3 months | -7.93% | ||
6 months | +17.54% | ||
Current year | -20.62% |
Managers | Title | Age | Since |
---|---|---|---|
Gyeong-Won Yoon
CEO | Chief Executive Officer | 52 | 03/01/03 |
Seong-Joon Yoon
CEO | Chief Executive Officer | 55 | 12/00/12 |
Jae-Goo Seol
BRD | Director/Board Member | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yoon-Sun Yang
BRD | Director/Board Member | 59 | - |
Seong-Joon Yoon
CEO | Chief Executive Officer | 55 | 12/00/12 |
Gyeong-Won Yoon
CEO | Chief Executive Officer | 52 | 03/01/03 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 6,970 | -1.13% | 134,078 |
29/24/29 | 7,050 | +2.47% | 119,835 |
26/24/26 | 6,880 | -0.29% | 61,742 |
25/24/25 | 6,900 | -1.57% | 48,466 |
24/24/24 | 7,010 | +0.43% | 49,983 |
End-of-day quote Korea S.E., April 30, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.62% | 167M | |
-2.72% | 102B | |
+2.21% | 96.09B | |
+2.13% | 22.28B | |
-17.09% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.94% | 16.09B | |
+6.12% | 13.83B | |
+32.06% | 11.97B |
- Stock Market
- Equities
- A048530 Stock